Mechanism identified for HBsAg reduction with Aligos Therapeutics STOPS molecule ALG-10000 July 9, 2021
New phase II/III study evaluates BLU-263 in patients with indolent systemic mastocytosis July 9, 2021
Ischemix awarded DoD funding to support phase I study of CMX-2043 for traumatic brain injury July 8, 2021